Compare RMTI & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMTI | NMTC |
|---|---|---|
| Founded | 1994 | 2009 |
| Country | United States | United States |
| Employees | 300 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7M | 29.2M |
| IPO Year | 2022 | 2010 |
| Metric | RMTI | NMTC |
|---|---|---|
| Price | $0.66 | $3.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $2.00 | ★ $11.90 |
| AVG Volume (30 Days) | ★ 316.2K | 25.8K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $69,258,000.00 | $9,097,692.00 |
| Revenue This Year | $8.64 | N/A |
| Revenue Next Year | $8.44 | $31.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $0.60 | $0.55 |
| 52 Week High | $2.10 | $5.40 |
| Indicator | RMTI | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 35.53 | 40.60 |
| Support Level | $0.60 | $0.69 |
| Resistance Level | $1.00 | $4.87 |
| Average True Range (ATR) | 0.04 | 0.21 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 26.60 | 27.69 |
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.